Table 2 Characteristics associated with the current hospitalization of 12,483 ICU patients with and without preadmission statin use, Aarhus University Hospital, Denmark, 2001 to 2007

Department

Medical

771 (41.0%)

4243 (40.0%)

Surgical

1111 (59.0%)

6358 (60.0%)

Main diagnosis

Infections

43 (2.3%)

253 (2.4%)

Cancer

163 (8.7%)

1607 (15.2%)

Diabetes

30 (1.6%)

129 (1.2%)

Cardiovascular

800 (42.5%)

2828 (26.7%)

Respiratory

132 (7.0%)

1049 (9.9%)

Gastrointestinal

163 (8.7%)

1187 (11.2%)

Trauma/poisoning

136 (7.2%)

1383 (13.1%)

Other

415 (22.0%)

2165 (20.4%)

Surgical status at ICU admission

Surgery within 7 days

199 (10.6%)

1347 (12.7%)

Mechanical ventilation

1021 (54.3%)

4796 (45.3%)

Renal replacement therapy

223 (11.9%)

867 (8.2%)

Laboratory findings, median (IQR)*

Hemoglobin (ref; female: 7.4-9.6 mmol/l, male:8.4-10.8 mmol/l)

7.10 (6.30-8.20)

7.30 (6.40-8.30)

Creatinine (ref 60-125 μmol/l)

106.5 (80-165)

93 (70-138)

Bilirubin (ref 4-21 mmol/l)

10 (7-16)

12 (8-20)

C-reactive protein (ref <10 mg/l)

80 (15-250)

97 (21-279)

White blood cell count

(ref 4.0-11.0 × 10⁹/l)

12.2 (8.8-16.0)

12.3 (9.0-16.7)

Total cholesterol (ref 3.0-6.7 mmol/l)

4.6 (3.9-5.5)

5.0 (4.1-5.9)